AIoT Health

AIoT Health, founded in 2020 and based in Calgary, Canada, focuses on enhancing healthcare through the integration of digital technology and machine learning. The company aims to improve treatment outcomes by analyzing how individuals within a cohort respond to various therapies, thereby paving the way for personalized medicine. By leveraging portable technology and biofeedback, AIoT Health seeks to increase patient engagement and facilitate continuous healthcare improvement without the necessity for new procedures or drugs. Their approach emphasizes the collection of longitudinal data to uncover new metrics and treatment options, ultimately striving to create a more nuanced understanding of individual health responses and advancing healthcare delivery.

Amol Deshpande MD

Partner

Kar Leung

Partner

Matt Mayer

Partner

4 past transactions

Arcascope

Seed Round in 2022
Arcascope makes apps that utilize algorithms that track circadian rhythms and generates personalized recommendations to help people get their clocks back on track.

SeamlessMD

Series A in 2020
SeamlessMD is a digital patient engagement platform focused on improving health outcomes after surgery. By collaborating with healthcare providers, SeamlessMD enhances patient experiences through technology, design, and data. The platform supports hospitals in remote patient monitoring, enabling the collection of data that can lead to better surgical outcomes and reduced readmissions. Ultimately, SeamlessMD aims to deliver quality surgical care while lowering costs, addressing the challenges faced by patients and providers in the surgical process.

DrugBank

Seed Round in 2020
DrugBank is a developer of a comprehensive drug knowledge platform aimed at enhancing healthcare delivery and accelerating drug research. Its extensive database offers detailed information about drugs, their mechanisms of action, and interactions, which aids healthcare professionals in making informed decisions. The platform includes tools for drug search, interaction checking, allergy information, and drug labeling, facilitating precision medicine and clinical software applications. By integrating its knowledge base into various software solutions, DrugBank enables companies to leverage advanced insights and data science for drug discovery, helping to identify novel drug candidates and opportunities for drug repurposing. Additionally, DrugBank Online serves as a publicly available resource, offering limited datasets for academic and non-commercial researchers. With over 13,000 citations in academic publications, DrugBank is widely utilized by researchers and health professionals worldwide.

Alio

Convertible Note in 2020
Alio is a company that specializes in remote patient monitoring technology aimed at improving care for patients, particularly those with dialysis-related complications. Founded in 2012 and based in Broomfield, Colorado, Alio's innovative devices measure various health metrics, including skin temperature, oxygen saturation, pulse rate variability, blood pressure, potassium levels, and hemoglobin. By providing patients with the tools to manage their health more effectively, the technology also equips physicians with actionable real-time data, enabling them to make informed medical decisions and reduce avoidable hospitalizations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.